CMND
Clearmind Medicine Inc. Common Shares
NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY
$0.52
+36.77% today
Updated 2026-06-05
Market cap
$4.06M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-241.20
Dividend yield
—
52W range
$2 – $524
Volume
9.2M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-8.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -8.11 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.08M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-9.93M | $-8.61M | $-5.25M | $-3.86M | $-3.85M |
| EPS | — | — | — | — | $-241.20 |
| Free cash flow | $-5.06M | $-6.30M | $-6.76M | $-4.73M | $-2.08M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Clearmind Medicine Inc. Common Shares trades at $0.52. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -8.11, it sits in the distress.
Frequently asked questions
What is Clearmind Medicine Inc. Common Shares's stock price?
Clearmind Medicine Inc. Common Shares (CMND) trades at $0.52.
Is Clearmind Medicine Inc. Common Shares overvalued?
Clearmind Medicine Inc. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Clearmind Medicine Inc. Common Shares's Altman Z-Score is -8.11, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-93.63%
Beta-1.24
50D MA$6.96
200D MA$133.85
Shares out0.00B
Float0.00B
Short ratio—
Avg volume9.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—